Tzung-Horng Yang

Title: Tzung-Horng Yang: Innovator in Hyaluronan-Degrading Enzymes

Introduction

Tzung-Horng Yang is a notable inventor based in Del Mar, California. He has made significant contributions to the field of biochemistry, particularly in the development of stable formulations of hyaluronan-degrading enzymes. His work has implications for various medical applications, including diabetes management.

Latest Patents

Tzung-Horng Yang holds a patent for "Stable formulations of a hyaluronan-degrading enzyme." This patent includes compositions that are stable formulations of a hyaluronan-degrading enzyme or stable co-formulations of a fast-acting insulin and a hyaluronan degrading enzyme, featuring a recombinant human PH20 (rHuPH20). This innovation is crucial for enhancing the efficacy of treatments involving insulin.

Career Highlights

Yang is associated with Halozyme, Inc., a company known for its pioneering work in enzyme technology. His role at Halozyme has allowed him to focus on developing innovative solutions that address critical health challenges. His expertise in enzyme formulations has positioned him as a key player in the biotechnology sector.

Collaborations

Tzung-Horng Yang has collaborated with notable colleagues, including Daniel Edward Vaughn and Michael James Labarre. These partnerships have fostered a collaborative environment that encourages innovation and the advancement of biotechnological research.

Conclusion

Tzung-Horng Yang's contributions to the field of hyaluronan-degrading enzymes exemplify the impact of innovative thinking in biotechnology. His work continues to influence medical treatments and improve patient outcomes.